Jay Meyer - Concepedia

Author

Jay Meyer

AstraZeneca (United Kingdom)

Also Known As

Brandon J. Essink, David Metzger, Jay Meyer, Jay W. Meyer

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Moderna Therapeutics (United States)

About

Jay Meyer is an author at AstraZeneca (United Kingdom) specializing in health services research, managed care, and outcomes research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	57
2	Public Health	2	2	67
3	Health Policy	2	2	67
4	Pharmacology	1	1	38
5	Pulmonary Medicine	1	1	38

Jay Meyer

Publications

483

Citations

H-Index

Page 1

	Year	Citations
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies Stuart Stoloff, David A. Stempel, Jay Meyer, Journal of Allergy and Clinical Immunology	2004	247
Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Jennifer S. Schultz, John C. O’Donnell, Ken McDonough, PubMed	2005	107
Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective David W. Lee, Jay Meyer, Jon Clouse Value in Health Disease ManagementHealthcare ValueHealth EconomicsHealth PolicyCase Study	2001	48
One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma David A. Stempel, Jay Meyer, Richard H. Stanford, Journal of Allergy and Clinical Immunology AsthmaMedicineAllergenFluticasone PropionatePulmonary Medicine	2001	38
Patterns and Effectiveness of Lipid-Lowering Therapies in a Managed Care Environment Jay Meyer, Jennifer S. Schultz, John C. O’Donnell, Value in Health Non-pharmacological InterventionLipid DisorderPreventive MedicineHealth PolicyClinical Effectiveness	2005	19
Risk of COVID-19 after natural infection or vaccination Anne-Marie Rick, Matthew B. Laurens, Ying Huang, EBioMedicine	2023	13
Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA Vaccine Spyros Chalkias, Antionette Pragalos, Adebayo Akinsola, The Journal of Infectious Diseases	2025	11

Page 1